Cue Biopharma is trading 5.93% up now at $31.78, with no clear catalyst identified.

  • The stock rose from the September 8 close of $30.00.
  • No company-specific announcement or regulatory catalyst dated September 9, 2026, was identified; the company’s latest listed updates predate today.
  • Major indexes are below 0.5%, so macro sentiment does not clearly explain the gain. The move may reflect continued volatility or trading activity.